Clarfeld Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Clarfeld Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$3K	Buy	+26	New	+$2.92K	﹤0.01%	417

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clarfeld Financial Advisors's ZBH Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Zimmer Biomet (ZBH) in Q4 2018: 26 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings.

872 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Clarfeld Financial Advisors held 26 shares of Zimmer Biomet worth $3K as of Q4 2018.
Zimmer Biomet was a new Clarfeld Financial Advisors position in Q4 2018.
Zimmer Biomet made up ﹤0.01% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #417 holding.
872 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.